Gentle Laxative
- Product NDC
- 21130-410
- 11-digit product format
- 211300410
- Labeler code
- 21130
- Product ID
- 21130-410_3eaa649e-0aa5-c65f-e063-6294a90a314e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bisacodyl
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- BETTER LIVING BRANDS LLC.
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-06-01
- Substance
- BISACODYL
- Active strength
- 5 mg/1
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 21130-410-20 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 21130-410-52 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 21130-410-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 21130-410-52 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 21130-410-20 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 21130-410-52 | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Gentle Laxative
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BISACODYL | 5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 10X0709Y6I | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 308753 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f29d57f6-0938-d459-e053-2995a90ad86b | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 21130-410-20 | 2025-02-11 | 14R_Albertsons_21130-410_Bisacodyl Delayed Release Tablets 5 mg |
| 21130-410-52 | 2025-02-11 | 14R_Albertsons_21130-410_Bisacodyl Delayed Release Tablets 5 mg |
| 21130-410-20 | 2025-01-30 | 14R_Albertsons_21130-410_Bisacodyl Delayed Release Tablets 5 mg |
| 21130-410-52 | 2025-01-30 | 14R_Albertsons_21130-410_Bisacodyl Delayed Release Tablets 5 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21130-410-20 | Gentle Laxative | 200 in 1 BOTTLE | TABLET, DELAYED RELEASE | 200 | 4 | |
| 21130-410-52 | Gentle Laxative | 25 in 1 BLISTER PACK | TABLET, DELAYED RELEASE | 25 | 4 | |
| 21130-410-52 | Gentle Laxative | 1 in 1 CARTON | TABLET, DELAYED RELEASE | 1 | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| WOMENS LAXATIVE ENTERIC COATED | BISACODYL | CARDINAL HEALTH | ab34bc89-6738-d284-e053-2a95a90a5dc9 | 2024-01-11 | Warnings | M007 |
| MAXIMUM STRENGTH LAXATIVE | SENNOSIDES | CARDINAL HEALTH | b7b13bfa-8a94-6f62-e053-2995a90abbf4 | 2024-01-10 | Warnings | M007 |
| FIBER LAXATIVE | CALCIUM POLYCARBOPHIL | Magno-Humphries, Inc. | e4a921c5-1cf7-12ca-e053-2a95a90a6e04 | 2024-01-03 | Warnings | M007 |
| Freskaro Castor Oil | CASTOR OIL | Pharma Nobis, LLC | fbd6bdd5-a7a1-3f28-e053-6294a90aab87 | 2023-12-28 | Warnings | M007 |
| Humco Castor Oil | CASTOR OIL | Pharma Nobis, LLC | e42f9d37-1b07-177a-e053-2a95a90a9b06 | 2023-12-26 | Warnings | M007 |
| Magnesium Citrate | FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON | Pharma Nobis, LLC | f0477328-eca1-9043-e053-2995a90aaa3d | 2023-12-22 | Warnings | M007 |
| Magnesium Citrate | FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | Pharma Nobis, LLC | f0489f6f-9e60-7d69-e053-2a95a90a9dfb | 2023-12-22 | Warnings | M007 |
| Magnesium Citrate | FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE | Pharma Nobis, LLC | f0488c86-6c74-3987-e053-2a95a90a31b4 | 2023-12-22 | Warnings | M007 |
| Mineral Oil Heavy | MINERAL OIL | Pharma Nobis, LLC | e42f6c6d-c4de-02c6-e053-2995a90a3ace | 2023-12-22 | Warnings | M007 |
| Quality Choice Castor Oil | CASTOR OIL | Chain Drug Market Asociation | 18d7124f-7745-45b2-adc4-cb1103add5d6 | 2023-12-20 | Warnings | M007 |
| Premiere Value Castor Oil | CASTOR OIL | Chain Drug Consortium | 5c8c1564-fcff-894b-e053-2991aa0a9c0b | 2023-12-20 | Warnings | M007 |
| Magnesium Citrate | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | Bionpharma, Inc. | f0fa4b72-50a5-5c42-e053-2995a90a159a | 2023-12-20 | Warnings | M007 |
| Harris Teeter Castor Oil | CASTOR OIL | Harris Teeter, LLC | 5cca6b4b-d88f-1c7d-e053-2991aa0a051f | 2023-12-20 | Warnings | M007 |
| Magnesium Citrate | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON | Bionpharma, Inc. | f0f9c36e-c43b-05d2-e053-2995a90a6d65 | 2023-12-20 | Warnings | M007 |
| Magnesium Citrate | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE | Bionpharma, Inc. | f0f9ff19-ae08-0af0-e053-2a95a90ab842 | 2023-12-20 | Warnings | M007 |
| CVS Mineral Oil | MINERAL OIL | CVS | 9d7402e1-524b-1084-e053-2a95a90ae3af | 2023-12-20 | Warnings | M007 |
| Top Care Castor Oil | CASTOR OIL | TOPCO ASSOCIATES LLC | 8dce1a1f-e765-9c75-e053-2995a90abf9f | 2023-12-18 | Warnings | M007 |
| Humco Epson Salt | MAGNESIUM SULFATE | Humco Holding Group, Inc. | 7a9d1b77-6c39-46f1-86f2-4059dde20f85 | 2023-12-15 | Warnings | M007 |
| Humco Mineral Oil Heavy | MINERAL OIL | Humco Holding Group, Inc. | 9f943fdf-5058-4e18-ba96-6be112bf72ca | 2023-12-15 | Warnings | M007 |
| Rite Aid Castor Oil | CASTOR OIL | Rite Aid Corporation. | 5e0d3664-b01b-ba28-e053-2991aa0a8a4c | 2023-12-15 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308753 | bisacodyl 5 MG Delayed Release Oral Tablet | PSN | f29d57f6-0938-d459-e053-2995a90ad86b | 4 |
| 308753 | bisacodyl 5 MG Delayed Release Oral Tablet | SCD | f29d57f6-0938-d459-e053-2995a90ad86b | 4 |
| 308753 | bisacodyl 5 MG Enteric Coated Oral Tablet | SY | f29d57f6-0938-d459-e053-2995a90ad86b | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 21130-410-20 | 21130041020 | 200 TABLET, DELAYED RELEASE in 1 BOTTLE (21130-410-20) | 2023-06-22 | No | No | Current | |
| 21130-410-52 | 21130041052 | 1 BLISTER PACK in 1 CARTON (21130-410-52) / 25 TABLET, DELAYED RELEASE in 1 BLISTER PACK | 1 blister pack | 2023-06-01 | No | No | Current |